Acumen Pharmaceuticals (ABOS) Institutional Ownership

$3.19
+0.01 (+0.31%)
(As of 04/25/2024 ET)

Institutional Ownership Changes (13F Filings) for Acumen Pharmaceuticals (NASDAQ:ABOS)

Current
Institutional Ownership
Percentage
71.01%
Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$50.14M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.60M
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ABOS Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2024Chicago Partners Investment Group LLC18,315$70K0.0%+34.9%0.032%
2/15/2024Parkman Healthcare Partners LLC603,497$2.32M0.3%+20.7%1.042%
2/9/2024Franklin Resources Inc.3,358,809$12.90M0.0%+18.3%5.800%
2/7/2024Jump Financial LLC103,000$396K0.0%+203.8%0.178%
12/7/2023Hudson Bay Capital Management LP525,000$2.18M0.0%+32.9%0.907%
12/6/2023Citigroup Inc.38,498$160K0.0%+5,423.4%0.066%
11/15/2023RA Capital Management L.P.14,932,063$61.97M1.2%+52.8%25.803%
11/15/2023Rock Springs Capital Management LP2,812,579$11.67M0.3%N/A4.860%
11/15/2023Laurion Capital Management LP1,895,023$7.86M0.0%+57.1%3.275%
11/14/2023Schonfeld Strategic Advisors LLC645,112$2.68M0.0%N/A1.115%
11/14/2023Knollwood Investment Advisory LLC1,628,510$6.76M3.2%N/A2.814%
11/13/2023 DekaBank Deutsche Girozentrale40,000$167K0.0%N/A0.069%
11/8/2023Pathstone Family Office LLC478,790$1.99M0.0%+2.5%0.827%
11/7/2023Jump Financial LLC33,900$141K0.0%N/A0.059%
11/3/2023Intrepid Financial Planning Group LLC30,150$125K0.1%+49.6%0.052%
10/26/2023Chicago Partners Investment Group LLC13,579$56K0.0%N/A0.023%
9/21/2023Baystate Wealth Management LLC18,020$87K0.0%N/A0.031%
8/14/2023Deep Track Capital LP3,916,361$18.84M0.9%-0.9%6.768%
8/14/2023Prelude Capital Management LLC31,100$150K0.0%N/A0.076%
8/2/2023 Catalyst Financial Partners LLC89,699$431K0.2%N/A0.219%
8/2/2023Baystate Wealth Management LLC18,020$87K0.0%N/A0.044%
7/27/2023Pinnacle Associates Ltd.18,020$87K0.0%N/A0.044%
5/16/2023Great Point Partners LLC1,051,267$4.27M0.8%-5.8%2.563%
5/15/2023Commodore Capital LP400,000$1.62M0.2%-19.7%0.975%
5/15/2023Guardian Point Capital LP130,000$528K0.4%-56.7%0.317%
5/3/2023Jump Financial LLC10,183$41K0.0%-52.1%0.025%
5/2/2023Intrepid Financial Planning Group LLC30,150$122K0.1%+201.5%0.073%
4/26/2023Chicago Partners Investment Group LLC12,332$47K0.0%-34.0%0.030%
2/14/2023Moore Capital Management LP27,578$149K0.0%-93.5%0.068%
2/14/2023683 Capital Management LLC31,246$169K0.0%N/A0.077%
2/14/2023Driehaus Capital Management LLC563,864$3.05M0.0%-1.3%1.392%
2/13/2023Pathstone Family Office LLC530,330$2.86M0.0%+109.4%1.309%
2/10/2023Cheyne Capital Management UK LLP55,829$301K0.5%N/A0.138%
2/9/2023Chicago Partners Investment Group LLC18,679$109K0.0%+68.5%0.046%
2/7/2023WMS Partners LLC98,301$531K0.1%-45.4%0.243%
2/2/2023Intrepid Financial Planning Group LLC10,000$54K0.0%N/A0.025%
2/1/2023Bank of Montreal Can58,400$326K0.0%N/A0.144%
11/15/2022Pathstone Family Office LLC253,270$2.54M0.0%N/A0.625%
11/15/2022Perceptive Advisors LLC400,000$4.01M0.1%-21.3%0.988%
11/15/2022Endurant Capital Management LP55,328$555K0.2%N/A0.137%
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.
11/15/2022Commodore Capital LP1,100,000$11.03M1.8%N/A2.716%
11/14/2022Point72 Asset Management L.P.40,936$411K0.0%N/A0.101%
11/14/2022Boothbay Fund Management LLC62,580$628K0.0%+391.7%0.155%
11/14/2022Moore Capital Management LP422,902$4.24M0.1%+18.0%1.044%
11/3/2022Barclays PLC34,161$342K0.0%+408.0%0.084%
10/28/2022Silverarc Capital Management LLC420,000$4.21M1.4%N/A1.037%
8/16/2022Woodline Partners LP426,170$2.00M0.0%-15.0%1.052%
8/15/2022Laurion Capital Management LP1,206,548$5.67M0.1%+83.7%2.979%
8/13/2022Virtu Financial LLC26,204$123K0.0%N/A0.065%
5/17/2022Great Point Partners LLC928,282$3.63M0.9%N/A2.292%
5/16/2022Deep Track Capital LP2,599,098$10.16M0.7%+34.5%6.418%
5/13/2022Fiduciary Group LLC10,000$31K0.0%N/A0.025%
5/10/2022WMS Partners LLC181,068$708K0.1%N/A0.447%
5/6/2022 Los Angeles Capital Management LLC56,592$221K0.0%N/A0.140%
5/5/2022New York State Common Retirement Fund23,981$94K0.0%+337.5%0.059%
4/21/2022Strs Ohio41,300$161K0.0%+24.0%0.102%
2/19/2022Woodline Partners LP480,681$3.25M0.0%+2.5%1.188%
2/14/2022Deep Track Capital LP1,933,040$13.07M0.9%N/A4.776%
2/8/2022Northern Trust Corp94,984$642K0.0%+8.7%0.235%
2/2/2022New York State Common Retirement Fund5,481$37K0.0%N/A0.014%
1/24/2022Strs Ohio33,300$225K0.0%+1,413.6%0.082%
11/16/2021Janus Henderson Group PLC860,181$12.77M0.0%N/A2.126%
11/16/2021Laurion Capital Management LP656,848$9.76M0.0%N/A1.623%
11/16/2021Moore Capital Management LP369,583$5.49M0.1%N/A0.913%
11/16/2021BVF Inc. IL289,663$4.30M0.2%N/A0.716%
11/15/2021Pura Vida Investments LLC75,000$1.12M0.0%N/A0.185%
11/15/2021Rock Springs Capital Management LP1,579,191$23.47M0.5%N/A3.902%
11/15/2021Marshall Wace LLP156,250$2.32M0.0%N/A0.386%
11/15/2021RA Capital Management L.P.9,770,773$145.19M2.0%N/A24.144%
11/15/2021Franklin Resources Inc.937,500$13.93M0.0%N/A2.317%
11/12/2021Geode Capital Management LLC107,806$1.60M0.0%N/A0.266%
11/10/2021Goldman Sachs Group Inc.63,635$946K0.0%N/A0.157%
11/9/2021BlackRock Inc.2,868,791$42.63M0.0%N/A7.089%
11/4/2021Sands Capital Ventures LLC3,417,075$50.78M7.7%N/A8.444%
11/4/2021Deutsche Bank AG5,518$82K0.0%N/A0.014%
(Data available from 1/1/2016 forward)

ABOS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABOS shares?

During the previous two years, 39 institutional investors and hedge funds held shares of Acumen Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($61.97M), Deep Track Capital LP ($18.84M), Franklin Resources Inc. ($12.90M), Rock Springs Capital Management LP ($11.67M), Laurion Capital Management LP ($7.86M), Knollwood Investment Advisory LLC ($6.76M), and Great Point Partners LLC ($4.27M).Learn more on ABOS's institutional investors.

What percentage of Acumen Pharmaceuticals stock is owned by institutional investors?

71.01% of Acumen Pharmaceuticals stock is owned by institutional investors. Learn more on ABOS's institutional investor holdings.

Which institutional investors have been buying Acumen Pharmaceuticals stock?

Of the 35 institutional investors that purchased Acumen Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($5.16M), Rock Springs Capital Management LP ($2.81M), Knollwood Investment Advisory LLC ($1.63M), Laurion Capital Management LP ($1.24M), Commodore Capital LP ($1.10M), Great Point Partners LLC ($928.28K), and Deep Track Capital LP ($666.06K).

How much institutional buying is happening at Acumen Pharmaceuticals?

Institutional investors have bought a total of 16,993,325 shares in the last 24 months. This purchase volume represents approximately $82.67M in transactions.

Which Acumen Pharmaceuticals major shareholders have been selling company stock?

Of the 11 institutional investors that sold Acumen Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Moore Capital Management LP ($395.32K), Guardian Point Capital LP ($170K), Perceptive Advisors LLC ($108.53K), Commodore Capital LP ($98.32K), WMS Partners LLC ($81.77K), Woodline Partners LP ($75.07K), and Great Point Partners LLC ($65.31K).

How much institutional selling is happening at Acumen Pharmaceuticals?

Institutional investors have sold a total of 1,054,920 shares in the last 24 months. This volume of shares sold represents approximately $5.66M in transactions.


This page (NASDAQ:ABOS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners